# Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)

> **NCT03217149** · NA · UNKNOWN · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 200 (estimated)

## Conditions studied

- ARDS

## Interventions

- **DRUG:** heliox combined with MV
- **DRUG:** MV

## Key facts

- **NCT ID:** NCT03217149
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-01
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-08-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03217149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03217149, "Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03217149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*